Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer
Conditions: Advanced Breast Cancer; Hormone Receptor Positive Breast Carcinoma; HER2-negative Breast Cancer Intervention: Sponsor: University of Milano Bicocca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | HER2 | Hormonal Therapy | Hormones | Research | Study